Based on promising results from phase III clinical trials, Health Canada has decided to extend the use of Kalydeco (ivacaftor) to include children aged 1 to 2 years.
ivacaftor
-
February 28, 2019
-
February 25, 2019
A recent clinical trial indicates that Symkevi/Symdeko (tezacaftor/ivacaftor) can safely and effectively loosen thick, sticky mucus for children 6-11 years old.
-
December 03, 2018
Australia provides reimbursement for cystic fibrosis medicine.